Overview
- 3 public-safe observations are available for this inspection.
- 1 structured CFR citation is represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
30 Jun 2022
21 CFR 111.75(a)(2)(ii)(E)
Documentation - quality control, review, approve supplier
Cited by Dhaval H Patel
30 Jun 2022
21 CFR 111.75(a)(2)(ii)(E)
Documentation - quality control, review, approve supplier
Cited by Dhaval H Patel
30 Jun 2022
21 CFR 111.75(a)(2)(ii)(E)
Documentation - quality control, review, approve supplier
Cited by Dhaval H Patel
Inspected site
LSLife Science Labs Manufacturing LLCLakewood, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 111.75(a)(2)(ii)(E) | Cited across public-safe Form 483 observations | 3x |
Full 483 report
Get the verbatim text of all 3 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere